The evidence leans constructive4 supporting, 1 against, 0 worth knowing
Supporting
trading 6% above its 200-day average
sitting at 90% of its 52-week range, with little overhead supply from trapped buyers
matches the market's strongest stocks, which has beaten the market by +0.59 points over 20 sessions across 51,498 past signals
5 independent kinds of evidence agree today, which is uncommon
Against
1 of the scans it matches has historically underperformed the market
Worth knowing
nothing the data supports either way
What would change this read: a close below 144, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working2
Trading 5.8% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+5.8%
3 different kinds of evidence point at it tonight, not 3 versions of the same one.
3 families
Needs watching
Nothing on this side tonight — not in the filings and not in the price.
Every figure here is computed — from the company’s own filings, or from its own closing prices. The wording is generated directly from the figures.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
5 of 47 matched on 10 Sep
CANHLIFE matches 5 of the 47 scans today, across 5 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
Management filings were typically +0.06pt vs the market over the next 5 sessions (n=2,634) · Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue rose in 2 of the last 3 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · standalone
4,347
32
—
—
—
Q4 FY26
31 Mar · standalone
1,268
39
—
—
—
Q3 FY26
31 Dec · standalone
4,273
31
—
—
—
Q2 FY26
30 Sep · standalone
2,349
45
—
—
—
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+1.6%
Versus 200-day average+5.8%
Below 52-week high-3.1%
Above 52-week low+40.3%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)45.4
Higher closes in last 53 of 5
Six-month return+3.44%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.